Koers LexaGene Holdings Inc. Toronto S.E.
Aandelen
LXG.H
CA52886L1031
Biotechnologie & Medisch Onderzoek
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jack Regan
CEO | Chief Executive Officer | - | 26-04-07 |
Jeffrey Mitchell
DFI | Director of Finance/CFO | - | 01-03-18 |
Steven Armstrong
COO | Chief Operating Officer | - | 24-03-20 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Joseph P. Caruso
BRD | Director/Board Member | 65 | 18-06-18 |
Jack Regan
CEO | Chief Executive Officer | - | 26-04-07 |
Tom Slezak
BRD | Director/Board Member | - | 12-10-16 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-27,31% | 9,41 mld. | |
+31,06% | 2,9 mld. | |
-14,31% | 2,16 mld. | |
-20,08% | 1,7 mld. | |
+66,87% | 1,51 mld. | |
+30,17% | 814 mln. | |
-1,97% | 760 mln. | |
-28,57% | 529 mln. | |
+5,17% | 312 mln. |